These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 1569402)

  • 1. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.
    Guéry JC; Neagu M; Rodriguez-Tarduchy G; Adorini L
    J Exp Med; 1993 May; 177(5):1461-8. PubMed ID: 8478615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
    Adorini L; Moreno J; Momburg F; Hämmerling GJ; Guéry JC; Valli A; Fuchs S
    J Exp Med; 1991 Oct; 174(4):945-8. PubMed ID: 1919443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
    Rosloniec EF; Gay D; Freed JH
    J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of T cell response with peptides is influenced by both peptide-binding specificity of major histocompatibility complex molecules and susceptibility of T cells to blocking.
    Lehmann PV; Cardinaux F; Appella E; Muller S; Falcioni F; Adorini L; Nagy ZA
    Eur J Immunol; 1989 Jun; 19(6):1071-7. PubMed ID: 2787751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the antigen binding region of an MHC class II molecule.
    Rosloniec EF; Beard KS; Freed JH
    Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of peptide antigen presentation by a second peptide.
    de Kroon AI; McConnell HM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8797-801. PubMed ID: 8105466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficiency of endogenous antigen presentation by MHC class II molecules.
    Calin-Laurens V; Forquet F; Lombard-Platet S; Bertolino P; Chrétien I; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Int Immunol; 1992 Oct; 4(10):1113-21. PubMed ID: 1336977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.
    Zhong G; Reis e Sousa C; Germain RN
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13856-61. PubMed ID: 9391117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
    Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
    Kanost D; Basten A; McCluskey J
    Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90).
    Kang HK; Mikszta JA; Deng H; Sercarz EE; Jensen PE; Kim BS
    J Immunol; 2000 Feb; 164(4):1775-82. PubMed ID: 10657624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells.
    Guéry JC; Ria F; Galbiati F; Smiroldo S; Adorini L
    Int Immunol; 1997 Jan; 9(1):9-15. PubMed ID: 9043943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.